Opportunity ID: 348966

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-CA-23-026
Funding Opportunity Title: Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.396 — Cancer Biology Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 28, 2023
Last Updated Date: Jun 28, 2023
Original Closing Date for Applications: Sep 14, 2023
Current Closing Date for Applications: Sep 14, 2023
Archive Date: Oct 20, 2023
Estimated Total Program Funding:
Award Ceiling: $1,500,000
Award Floor:

Eligibility

Eligible Applicants: Private institutions of higher education
For profit organizations other than small businesses
Independent school districts
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
State governments
County governments
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this funding opportunity is to advance cancer control equity research by stimulating community-engaged, multilevel research interventions that address the impact of social determinants of health on adverse cancer outcomes. Applicants will 1) develop interventions that target the multilevel pathways by which social determinants of health impact adverse cancer outcomes; 2) develop methods, measures, and assess community-level SDOH, community engagement, and cancer control equity processes and outcomes; and 3) build capacity among diverse scholars, stakeholders, and community partners to implement interventions that incorporate the lived experiences of those who face cancer inequities.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-026.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 348966 Full Announcement-RFA-CA-23-026 -> RFA-CA-23-026-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00282348 Aug 14, 2023 Sep 14, 2023 View

Package 1

Mandatory forms

348966 RR_SF424_5_0-5.0.pdf

348966 PHS398_CoverPageSupplement_5_0-5.0.pdf

348966 RR_OtherProjectInfo_1_4-1.4.pdf

348966 PerformanceSite_4_0-4.0.pdf

348966 RR_KeyPersonExpanded_4_0-4.0.pdf

348966 PHS398_ResearchPlan_5_0-5.0.pdf

348966 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

348966 PHS_Additional_IndirectCosts_2_0-2.0.pdf

348966 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T04:52:38-05:00

Share This Post, Choose Your Platform!

About the Author: